James H. Sabry, Executive Chairman at CYTOKINETICS INC (CYTK), sold 40,000 shares at $2.96 ($114K) on 2009-06-29, disclosed to the SEC on 2009-06-30.
Open-market sale of $114k CYTK by Executive Chairman. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.83 | 10,600 | $30K | 26.3% |
| 2 | $2.84 | 800 | $2K | 2.0% |
| 3 | $2.84 | 8,300 | $24K | 20.7% |
| 4 | $2.85 | 300 | $855 | 0.8% |
| 5 | $2.79 | 1,300 | $4K | 3.2% |
| 6 | $2.80 | 200 |
| $560 |
| 0.5% |
| 7 | $2.80 | 2,041 | $6K | 5.0% |
| 8 | $2.81 | 2,663 | $7K | 6.6% |
| 9 | $2.82 | 200 | $564 | 0.5% |
| 10 | $2.83 | 696 | $2K | 1.7% |
| 11 | $2.84 | 800 | $2K | 2.0% |
| 12 | $2.85 | 2,200 | $6K | 5.5% |
| 13 | $2.86 | 1,800 | $5K | 4.5% |
| 14 | $2.87 | 1,000 | $3K | 2.5% |
| 15 | $2.88 | 600 | $2K | 1.5% |
| 16 | $2.89 | 1,100 | $3K | 2.8% |
| 17 | $2.90 | 100 | $290 | 0.3% |
| 18 | $2.90 | 1,489 | $4K | 3.8% |
| 19 | $2.92 | 900 | $3K | 2.3% |
| 20 | $2.94 | 300 | $882 | 0.8% |
| 21 | $2.95 | 411 | $1K | 1.1% |
| 22 | $2.96 | 100 | $296 | 0.3% |
| 23 | $2.97 | 400 | $1K | 1.0% |
| 24 | $2.98 | 700 | $2K | 1.8% |
| 25 | $2.98 | 100 | $298 | 0.3% |
| 26 | $2.99 | 600 | $2K | 1.6% |
| 27 | $2.99 | 300 | $897 | 0.8% |
| Total | $2.85 avg | 40,000 | $114K | 100% |
| Filing → |
| CYTK | SELL | 2010-05-14 | $30K | — | Filing → |
| CYTK | SELL | 2010-04-28 | $32K | — | Filing → |
| CYTK | SELL | 2010-04-01 | $32K | — | Filing → |